Hydromer®, Inc. (the “Company”) is an ISO 9001:2015 polymer research and development company that develops polymeric complexes for commercial use in the medical, commercial, cosmetics and other markets.
Hydromer became a public company in September 1982. The company’s symbol is HYDI, and company shares trade on the pink sheets platform. Trading in the company’s stock has been limited.
The approximate number of holders of record of the Common Stock on October 31, 2018 was 173. There are approximately 250 individual shareholders of the Common Stock.
Up to and including the Quarterly results for the three and six months ended December 31, 2013, all SEC documents are accessible online through the SEC Filings page. For the subsequent periods, the Company’s quarterly and annual reports can be found at http://www.otcmarkets.com/stock/HYDI/filings
Fill out or form below the FAQ’s to be added to our emailing list!
Due to the increasing compliance and regulatory burdens of listing as a SEC registrant, which is highly disproportionate for smaller reporting entities like Hydromer, Inc, the Company terminated as a SEC registrant on May 8, 2013. Nonetheless, the Company continued to report on the same basis and transparency levels while availing senior management more time to focus on more strategic initiatives.
Hydromer common stock can be bought or sold through a stockbroker or any financial institution that provides brokerage services.
Our fiscal year ends on June 30th.
Contact our finance team for more information or mail all investor inquiries to:
Hydromer, Inc.
Investor Relations
4715 Corporate Drive, Suite 200
Concord, NC 28027
Phone: 800-208-0314
Fax: (908) 526-3633
